IHE · iShares U.S. Pharmaceuticals ETF ETF
iShares Trust
$104.68
-0.70%
At close · Sep 4
Net assets $1,138,327,188
Holdings59
1 month
+2.16%
Year to date
+24.18%
52-week range
$69.02–$108.66
30-session avg volume
231,369
Market performance
Adjusted close · up to five years
Fund profile
- Structure
- Open-end / ETF
- SEC series
- S000009417
- Report date
- Jun 30, 2026
- Holdings coverage
- Full reported portfolio
Portfolio concentration
Top 10 holdings79.55%
Calculated only when the SEC filing is stored with complete portfolio coverage.
Asset allocation
EC99.92%
STIV6.31%
DE0.00%
Country allocation
US96.39%
GB4.33%
IE3.78%
CA1.39%
SG0.20%
KY0.15%
Portfolio holdings
Latest linked SEC Form NPORT-P report.
| Holding | Ticker / CUSIP | Value | Weight |
|---|---|---|---|
| JOHNSON & JOHNSON | JNJ | $255,484,677 | 22.44% |
| ELI LILLY AND COMPANY | LLY | $253,226,060 | 22.25% |
| BlackRock Funds III: BlackRock Cash Funds: Institutional; SL Agency Shares | 066922519 | $71,059,530 | 6.24% |
| MERCK & CO., INC. | MRK | $51,774,064 | 4.55% |
| BRISTOL-MYERS SQUIBB COMPANY | BMY | $49,725,657 | 4.37% |
| ROYALTY PHARMA PLC | RPRX | $49,346,478 | 4.33% |
| VIATRIS INC. | VTRS | $48,049,609 | 4.22% |
| PFIZER INC. | PFE | $45,133,457 | 3.96% |
| ZOETIS INC. | ZTS | $42,416,155 | 3.73% |
| JAZZ PHARMACEUTICALS PUBLIC LIMITED COMPANY | JAZZ | $39,283,652 | 3.45% |
| ELANCO ANIMAL HEALTH INCORPORATED | ELAN | $31,936,200 | 2.81% |
| AXSOME THERAPEUTICS, INC. | AXSM | $27,490,363 | 2.41% |
| CORCEPT THERAPEUTICS INCORPORATED | CORT | $21,584,729 | 1.90% |
| LIGAND PHARMACEUTICALS INCORPORATED | LGND | $16,458,806 | 1.45% |
| Definium Therapeutics Inc | DFTX | $15,807,086 | 1.39% |
| Liquidia Corp | LQDA | $14,553,595 | 1.28% |
| INDIVIOR PHARMACEUTICALS, INC. | INDV | $12,997,565 | 1.14% |
| Crinetics Pharmaceuticals Inc | 22663K107 | $10,250,685 | 0.90% |
| ORGANON & CO. | OGN | $9,248,199 | 0.81% |
| Edgewise Therapeutics Inc | EWTX | $7,959,173 | 0.70% |
| AMNEAL PHARMACEUTICALS, INC. | AMRX | $7,756,247 | 0.68% |
| Enliven Therapeutics Inc | ELVN | $7,177,826 | 0.63% |
| SUPERNUS PHARMACEUTICALS, INC. | SUPN | $7,021,196 | 0.62% |
| Tarsus Pharmaceuticals Inc | TARS | $6,469,351 | 0.57% |
| Veradermics Inc | MANE | $6,400,871 | 0.56% |
| Alumis Inc | ALMS | $6,233,601 | 0.55% |
| NEKTAR THERAPEUTICS | NKTR | $6,134,763 | 0.54% |
| PRESTIGE CONSUMER HEALTHCARE INC. | PBH | $5,813,454 | 0.51% |
| Trevi Therapeutics Inc | TRVI | $5,716,430 | 0.50% |
| OCULAR THERAPEUTIX, INC. | OCUL | $4,472,499 | 0.39% |
| INNOVIVA, INC. | INVA | $4,140,147 | 0.36% |
| Amylyx Pharmaceuticals Inc | AMLX | $3,944,232 | 0.35% |
| ANI PHARMACEUTICALS, INC. | ANIP | $3,924,103 | 0.34% |
| MBX Biosciences Inc | MBX | $3,822,434 | 0.34% |
| HARMONY BIOSCIENCES HOLDINGS, INC. | HRMY | $3,779,504 | 0.33% |
| PERRIGO COMPANY PUBLIC LIMITED COMPANY | PRGO | $3,735,496 | 0.33% |
| HARROW, INC. | HROW | $3,661,509 | 0.32% |
| NUVATION BIO INC. | NUVB | $3,598,854 | 0.32% |
| XERIS BIOPHARMA HOLDINGS, INC. | XERS | $3,552,128 | 0.31% |
| Rapport Therapeutics Inc | RAPP | $3,105,248 | 0.27% |
| Collegium Pharmaceutical, Inc. | COLL | $3,049,379 | 0.27% |
| EYEPOINT, INC. | EYPT | $2,926,624 | 0.26% |
| AtaiBeckley Inc | ATAI | $2,667,463 | 0.23% |
| PACIRA BIOSCIENCES, INC. | PCRX | $2,590,480 | 0.23% |
| WAVE Life Sciences Ltd | WVE | $2,290,482 | 0.20% |
| Maze Therapeutics Inc | MAZE | $2,183,094 | 0.19% |
| LB Pharmaceuticals Inc | LBRX | $2,050,280 | 0.18% |
| BIOAGE Labs Inc | BIOA | $2,032,810 | 0.18% |
| Septerna Inc | SEPN | $1,996,171 | 0.18% |
| AMPHASTAR PHARMACEUTICALS, INC. | AMPH | $1,785,789 | 0.16% |